Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
1507
mi
from 91732
Robbinsdale, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
1507
mi
from 91732
Robbinsdale, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Mayo Clinic Cancer Center
1524
mi
from 91732
Rochester, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Mayo Clinic Cancer Center
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
CentraCare Clinic - River Campus
1484
mi
from 91732
Saint Cloud, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
CentraCare Clinic - River Campus
1484
mi
from 91732
Saint Cloud, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Coborn Cancer Center
1484
mi
from 91732
Saint Cloud, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Coborn Cancer Center
1484
mi
from 91732
Saint Cloud, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
CCOP - Metro-Minnesota
1505
mi
from 91732
Saint Louis Park, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
CCOP - Metro-Minnesota
1505
mi
from 91732
Saint Louis Park, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Park Nicollet Cancer Center
1505
mi
from 91732
Saint Louis Park, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Park Nicollet Cancer Center
1505
mi
from 91732
Saint Louis Park, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
United Hospital
1515
mi
from 91732
Saint Paul, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
United Hospital
1515
mi
from 91732
Saint Paul, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Ridgeview Medical Center
1483
mi
from 91732
Waconia, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Ridgeview Medical Center
1483
mi
from 91732
Waconia, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Willmar Cancer Center at Rice Memorial Hospital
1433
mi
from 91732
Willmar, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Willmar Cancer Center at Rice Memorial Hospital
1433
mi
from 91732
Willmar, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Minnesota Oncology and Hematology PA-Woodbury
1522
mi
from 91732
Woodbury, MN
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Minnesota Oncology and Hematology PA-Woodbury
1522
mi
from 91732
Woodbury, MN
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
CCOP - Montana Cancer Consortium
951
mi
from 91732
Billings, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
CCOP - Montana Cancer Consortium
951
mi
from 91732
Billings, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Hematology-Oncology Centers of the Northern Rockies - Billings
949
mi
from 91732
Billings, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Hematology-Oncology Centers of the Northern Rockies - Billings
949
mi
from 91732
Billings, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Northern Rockies Radiation Oncology Center
949
mi
from 91732
Billings, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Northern Rockies Radiation Oncology Center
949
mi
from 91732
Billings, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
St. Vincent Healthcare Cancer Care Services
949
mi
from 91732
Billings, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
St. Vincent Healthcare Cancer Care Services
949
mi
from 91732
Billings, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Billings Clinic - Downtown
948
mi
from 91732
Billings, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Billings Clinic - Downtown
948
mi
from 91732
Billings, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Bozeman Deaconess Cancer Center
885
mi
from 91732
Bozeman, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Bozeman Deaconess Cancer Center
885
mi
from 91732
Bozeman, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
St. James Healthcare Cancer Care
873
mi
from 91732
Butte, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
St. James Healthcare Cancer Care
873
mi
from 91732
Butte, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Big Sky Oncology
990
mi
from 91732
Great Falls, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Big Sky Oncology
990
mi
from 91732
Great Falls, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Great Falls Clinic - Main Facility
990
mi
from 91732
Great Falls, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Great Falls Clinic - Main Facility
990
mi
from 91732
Great Falls, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Sletten Cancer Institute at Benefis Healthcare
990
mi
from 91732
Great Falls, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Sletten Cancer Institute at Benefis Healthcare
990
mi
from 91732
Great Falls, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Clinical Research Facility
991
mi
from 91732
Great Falls, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Clinical Research Facility
991
mi
from 91732
Great Falls, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
St. Peter's Hospital
919
mi
from 91732
Helena, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
St. Peter's Hospital
919
mi
from 91732
Helena, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Glacier Oncology, PLLC
994
mi
from 91732
Kalispell, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Glacier Oncology, PLLC
994
mi
from 91732
Kalispell, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Kalispell Medical Oncology at KRMC
994
mi
from 91732
Kalispell, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Kalispell Medical Oncology at KRMC
994
mi
from 91732
Kalispell, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Kalispell Regional Medical Center
994
mi
from 91732
Kalispell, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Kalispell Regional Medical Center
994
mi
from 91732
Kalispell, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Community Medical Center
906
mi
from 91732
Missoula, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Community Medical Center
906
mi
from 91732
Missoula, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Guardian Oncology and Center for Wellness
906
mi
from 91732
Missoula, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Guardian Oncology and Center for Wellness
906
mi
from 91732
Missoula, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Montana Cancer Specialists at Montana Cancer Center
907
mi
from 91732
Missoula, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Montana Cancer Specialists at Montana Cancer Center
907
mi
from 91732
Missoula, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Montana Cancer Center
911
mi
from 91732
Missoula, MT
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Montana Cancer Center
911
mi
from 91732
Missoula, MT
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Cancer Resource Center - Lincoln
1256
mi
from 91732
Lincoln, NE
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Cancer Resource Center - Lincoln
1256
mi
from 91732
Lincoln, NE
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
CCOP - Missouri Valley Cancer Consortium
1297
mi
from 91732
Omaha, NE
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
CCOP - Missouri Valley Cancer Consortium
1297
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Immanuel Medical Center
1297
mi
from 91732
Omaha, NE
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Immanuel Medical Center
1297
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
1294
mi
from 91732
Omaha, NE
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Alegent Health Cancer Center at Bergan Mercy Medical Center
1294
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Creighton University Medical Center
1299
mi
from 91732
Omaha, NE
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Creighton University Medical Center
1299
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Rutherford Hospital
2036
mi
from 91732
Rutherfordton, NC
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Rutherford Hospital
2036
mi
from 91732
Rutherfordton, NC
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Bismarck Cancer Center
1259
mi
from 91732
Bismarck, ND
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Bismarck Cancer Center
1259
mi
from 91732
Bismarck, ND
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Medcenter One Hospital Cancer Care Center
1259
mi
from 91732
Bismarck, ND
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Medcenter One Hospital Cancer Care Center
1259
mi
from 91732
Bismarck, ND
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Mid Dakota Clinic, PC
1259
mi
from 91732
Bismarck, ND
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Mid Dakota Clinic, PC
1259
mi
from 91732
Bismarck, ND
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
St. Alexius Medical Center Cancer Center
1264
mi
from 91732
Bismarck, ND
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
St. Alexius Medical Center Cancer Center
1264
mi
from 91732
Bismarck, ND
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
CCOP - MeritCare Hospital
1400
mi
from 91732
Fargo, ND
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
CCOP - MeritCare Hospital
1400
mi
from 91732
Fargo, ND
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Sanford Broadway Clinic
1400
mi
from 91732
Fargo, ND
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Sanford Broadway Clinic
1400
mi
from 91732
Fargo, ND
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Altru Cancer Center at Altru Hospital
1442
mi
from 91732
Grand Forks, ND
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Altru Cancer Center at Altru Hospital
1442
mi
from 91732
Grand Forks, ND
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Mary Rutan Hospital
1921
mi
from 91732
Bellefontaine, OH
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Mary Rutan Hospital
1921
mi
from 91732
Bellefontaine, OH
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Wood County Oncology Center
1930
mi
from 91732
Bowling Green, OH
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Wood County Oncology Center
1930
mi
from 91732
Bowling Green, OH
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Adena Regional Medical Center
1962
mi
from 91732
Chillicothe, OH
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Adena Regional Medical Center
1962
mi
from 91732
Chillicothe, OH
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Riverside Methodist Hospital Cancer Care
1958
mi
from 91732
Columbus, OH
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Riverside Methodist Hospital Cancer Care
1958
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
CCOP - Columbus
1960
mi
from 91732
Columbus, OH
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
CCOP - Columbus
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Grant Medical Center Cancer Care
1960
mi
from 91732
Columbus, OH
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Grant Medical Center Cancer Care
1960
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Mount Carmel West Hospital
1959
mi
from 91732
Columbus, OH
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Mount Carmel West Hospital
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated:  9/14/2015
Doctors Hospital at Ohio Health
1953
mi
from 91732
Columbus, OH
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Long Acting Methylphenidate (Concerta™) for Cancer-Related Fatigue: A Phase III, Randomized, Double-Blind Placebo Controlled Study
Status: Enrolling
Updated: 9/14/2015
Doctors Hospital at Ohio Health
1953
mi
from 91732
Columbus, OH
Click here to add this to my saved trials